DLK Investment Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-800
Closed -$234K 106
2026
Q1
$234K Hold
800
0.09% 71
2025
Q4
$280K Hold
800
0.1% 68
2025
Q3
$258K Buy
+800
New +$249K 0.1% 68

Other funds holding ELV

DLK Investment Management's ELV Position: Q2 2026 in Review

DLK Investment Management sold out of Elevance Health (ELV) in Q2 2026, closing a stake of 800 shares — an estimated $234K sold.

DLK Investment Management first reported a position in ELV in Q3 2025 and held it in 3 quarters. The position peaked at $280K in Q4 2025. 417 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • DLK Investment Management reported no remaining Elevance Health position as of Q2 2026 after selling out during the quarter.
  • DLK Investment Management sold 800 Elevance Health shares in Q2 2026, an estimated $234K.
  • DLK Investment Management first reported a position in Elevance Health in Q3 2025 and held it in 3 quarters.
  • DLK Investment Management's Elevance Health position peaked at $280K in Q4 2025.
  • 417 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on DLK Investment Management's 13F filing for Q2 2026, filed 14 Jul 2026.